BMAL1 alleviates sepsis-induced AKI by inhibiting ferroptosis.

Songyuan YangZehua YeWu ChenPeihan WangShen ZhaoXiangjun ZhouWei LiFan Cheng
Published in: International immunopharmacology (2024)
This study demonstrates that BMAL1 overexpression alleviates renal tubular epithelial cell injury and ferroptosis by inhibiting YAP expression and the Hippo pathway, thereby exerting protective effects in sepsis-induced AKI. These findings underscore the therapeutic potential of targeting BMAL1 in managing sepsis-induced AKI.